Meet Dr Philippe GABANT from Syngulon on our online Master Session #3 on 8 October 2020 at 10AM

Meet Dr Philippe GABANT from Syngulon on our online Master Session #3 on 8 October 2020 at 10AM

Philippe GABANT obtained his PhD in Molecular Biology from the Université Libre de Bruxelles (ULB) in 1993, and his Masters in Innovation Management from ISC Saint-Louis (Brussels, Belgium) in 1995.
In 1995-1996 he undertook post-doctoral research at the University of Edinburgh in the UK.  During his research he discovered, using mouse models, the function of alpha-fetoprotein, the major embryonic plasma protein in mammalian development.  
During his academic research career he has been involved as an inventor in the development of a portfolio of genetic selection patented technologies. 

One of these technologies, belonging to ULB, was licensed to Life technologies and has been on the market since 1995. Today it is a standard in DNA assembly method: Gateway technology, TOPO cloning,…

Since 2013 Philippe has been the founder and Chief Scientific Officer of Syngulon, a start-up focusing on genetic innovations to improve the control of microbial population using bacteriocins (antimicrobial peptides). Philippe has established several partnerships for the company with academics and industries.

Topic Title
Bacteriocin applications in the age of synthetic biology

The broad physiological activities of microbes are pillars of our planet’s ecological evolution. Balanced microbiomes are essential for all living organisms on the planet, including humans. The huge potential of microbe physiology has been used empirically by humankind for centuries in food and beverage processing and in many other industries. Due to environmental issues, energy and chemical production faces the challenge of shifting from an oil-based to a bio-based industry mobilising microbial biotechnology. This requires the development of new technologies based on synthetic biology to control industrial microbiomes. Here we briefly describe natural microbiomes to draw parallels with industrial bio-based production environments. We suggest that bacteriocins - a.k.a. anti-microbial peptides - can potentially become elements of an industrial genetic firewall to stabilise and protect these environments.

Each Master Session will take up to 2 hours from 10 AM till noon and will be themed according to the following specific subjects:
Session #1New (bio)resources – 10 September 2020
Session #2New (bio)products – 24 September 2020
Session #3: New technologies > industrial micro bio network ­– 8 October 2020
Session #4: New technologies > enzymatic and extraction technologies – 29 October 2020

The detailed programme and list of speakers is available on the PDF here below.

How to register?

You can register for one or several sessions, à la carte so to speak. Should you opt for a registration to all sessions (full menu formula), a discount will be applied.

Pricing (VAT excluded):
> Members*: €50.00  per Master Session & €170  for the whole series of 4 sessions 
> Non-Members : €75.00 per Master Session & €250.00 for the whole series of 4 sessions 

(*) fee applicable for all members of the Walloon Innovation Clusters. If you are member of another Walloon Innovation Cluster (Wagralim, BioWin, Logistics In Wallonia, Mecatech, SkyWin), please, send a proof of your membership to the following address:

Payment has to be made via this payment platform prior to registration process.

Cancellation policy: Please note that no refund will be made for cancellation. However, the registered person may be replaced. In that case, GreenWin has to be informed as soon as possible, and provided with the full details of the surrogate participant, at the following address: